Financial Data and Key Metrics Changes - Net operating income increased by 84% and hold dollars rose by 94% on a per share basis, driven by improved product margins and investment returns [6][75] - Free cash flow generation was strong, with Holdco liquidity benefiting from a $700 million debt offering in May [6][83] - Book value per diluted share, excluding AOCI, was $36, up 11% [76] Business Line Data and Key Metrics Changes - Life and Health NAP sales increased by 18%, marking the second highest quarter ever for the Worksite Division [3][70] - Fee sales were up 24%, reflecting the annual contract value of benefit services sold in the quarter [3] - Long-Term Care NAP surged by 88%, driven by the success of the Long-Term Care Fundamental Plus product [79] - Life production decreased due to lower spending on direct-to-consumer marketing, with a reduction in television marketing spend [80] Market Data and Key Metrics Changes - Total new annualized premium (NAP) was up 4% across the enterprise, with field sales NAP up 8% [70] - Medicare Supplement NAP increased by 16%, while Medicare Advantage sales rose by 78% [77] - Client assets in brokerage and advisory grew by 24% to a record $3.6 billion [91] Company Strategy and Development Direction - The company is focused on optimizing results post-COVID and is committed to driving return on equity (ROE) upwards [12] - The strategy includes geographic expansion and new product launches to enhance market share and sales growth [92] - The company aims to maintain a disciplined approach to deploying excess capital, with a focus on share repurchases [25][32] Management's Comments on Operating Environment and Future Outlook - Management expressed satisfaction with the progress but emphasized that they are not yet satisfied with the results, indicating a commitment to continuous improvement [12] - The outlook remains strong, with expectations of continued growth driven by demographic trends, particularly in the Medicare market [78][63] - Management noted that while claims experience can fluctuate, the current favorable trends are expected to continue [107] Other Important Information - The market value of invested assets grew by 5%, with 97% of the fixed maturity portfolio rated investment-grade [82] - The consolidated RBC ratio was 394% at quarter end, indicating a strong capital position [83] - The company raised guidance on operating earnings per share to $3.30 to $3.50 for the full year, reflecting strong second-quarter results [84] Q&A Session All Questions and Answers Question: Can you provide more details on claim trends within long-term care? - Management noted favorable claims experience contributing to margins, with expectations for this trend to continue [15] Question: Should we expect higher levels of cash flows going towards buybacks in 2024? - Management indicated that while they will remain disciplined, there is an opportunity to accelerate share repurchases due to excess capital from the recent debt offering [16][25] Question: What drove the margin improvement in Med Supp and Traditional Life? - Management highlighted growth in the block and lower advertising expenses as key drivers of margin benefits [62] Question: Can you comment on the productivity of new agents hired in the past two years? - Management expressed confidence in continued growth in agent counts and productivity, emphasizing the importance of productivity over raw account numbers [29][42] Question: What drove the reserve release in other annuities? - Management explained that the reserve release was driven by higher mortality in a small block of payout annuities, which is expected to remain volatile [60]

1 2 consider the important risks and uncertainties that may cause actual results to differ, including those included in our press release issued on July 29, 2024, our Quarterly Reports on Form 10-Q, our Annual Report on Form 10-K and other filings we make with the Securities and Exchange Commission. We assume no obligation to update this presentation, which speaks as of today's date. Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securi ...

For the quarter ended June 2024, CNO Financial (CNO) reported revenue of $1.07 billion, up 4.2% over the same period last year. EPS came in at $1.05, compared to $0.54 in the year-ago quarter. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. Here is how CNO performed in the just reported quarter in terms of the metrics m ...

This quarterly report represents an earnings surprise of 45.83%. A quarter ago, it was expected that this insurance holding company would post earnings of $0.64 per share when it actually produced earnings of $0.52, delivering a surprise of -18.75%. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. What's Next for CNO? There are no easy answers to this key ques ...

Quarterly Financial Supplement - 2Q2024 Page 1 Page 2 Page 3 Exhibit 99.2 July 29, 2024 | --- | --- | |-----------------------------------------------------------------------------------------------------------------------------|-------| | Table of Contents | Page | | Consolidated balance sheet | 3 | | Consolidated statement of operations | 4 | | Financial summary | 5 | | Insurance operations | 6 | | Margin from insurance products | 7-9 | | Collected premiums and insurance policy income | 10 | | Health and ...

Earnings per share up 66%; Operating earnings per share up 94% CARMEL, Ind., July 29, 2024 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE: CNO) today reported net income of $116.3 million, or $1.06 per diluted share, in 2Q24 compared to $73.7 million, or $0.64 per diluted share, in 2Q23. Net operating income (1) was $114.6 million, or $1.05 per diluted share, in 2Q24 compared to $62.3 million, or $0.54 per diluted share, in 2Q23. "CNO delivered excellent earnings and operating performance across the board, ...

Los Angeles, California--(Newsfile Corp. - July 26, 2024) - California Nanotechnologies Corp. (TSXV: CNO) (OTC Pink: CANOF) ("Cal Nano" or the "Company") has granted 1,300,000 incentive stock options to the employees, directors and officers of the Company. The options were granted pursuant to the Company's Stock Option Plan and received approval by Board of Directors Resolution on July 25, 2024. The options were granted at the exercise price of $0.83 CAD per share which was the most recent closing price. Th ...

CARMEL, Ind., July 15, 2024 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE: CNO) will report results for the second quarter of 2024 after the market closes on Monday, July 29, 2024. The company will host a conference call to discuss results at 11:00 a.m. Eastern Time on Tuesday, July 30, 2024. Participate by Dial-In To participate, please register here. Upon registering, you will be provided with call details and a registrant ID used to track attendance on the conference call. Reminders will also be sent t ...

Los Angeles, California--(Newsfile Corp. - July 9, 2024) - California Nanotechnologies Corp. (TSXV: CNO) (OTC Pink: CANOF) ("Cal Nano" or the "Company") is pleased to announce record quarterly revenues of US$1,748,826 for the fiscal quarter ending May 31, 2024. This represents an increase of 243% compared to the same period last year. Financial Highlights The increase in revenue for Q1/FY2025 was attributed to the ramp-up of manufacturing programs and two SPS equipment deliveries to University of Connecticu ...

New facility progressing well with equipment expected to be commissioned in August 2024 Net income for the fiscal year was US$381,678, compared to US$79,764 in the same period last year, while adjusted EBITDA1 was US$1,157,141, compared to US$384,174 for the same period last year. A net loss of US$318,359 was recorded for the quarter ended February 29, 2024, compared to a net loss of US$8,811, while adjusted EBITDA was US$325,326, compared to US$73,025 for the same period last year. "FY2024 was a transforma ...